Se-Aspirin

CAS No. 1850293-95-6

Se-Aspirin( —— )

Catalog No. M33763 CAS No. 1850293-95-6

Se-Aspirin (Se-NSAID-8) has anticancer activity and gastroprotective effects, inhibits activation of proinflammatory and pro-survival NF-?B pathways, and inhibits the expression of anti-apoptotic targets downstream of NF-?B (e.g., Bcl-xL, Mcl-1, and survivin).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 207 Get Quote
5MG 320 Get Quote
10MG 502 Get Quote
25MG 1030 Get Quote
50MG 1711 Get Quote
100MG 2241 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Se-Aspirin
  • Note
    Research use only, not for human use.
  • Brief Description
    Se-Aspirin (Se-NSAID-8) has anticancer activity and gastroprotective effects, inhibits activation of proinflammatory and pro-survival NF-?B pathways, and inhibits the expression of anti-apoptotic targets downstream of NF-?B (e.g., Bcl-xL, Mcl-1, and survivin).
  • Description
    Se-Aspirin (Se-NSAID-8) has anticancer activity and gastroprotective effects, inhibits activation of proinflammatory and pro-survival NF-?B pathways, and inhibits the expression of anti-apoptotic targets downstream of NF-?B (e.g., Bcl-xL, Mcl-1, and survivin).Se-Aspirin induces Cell cycle arrest and activation of apoptosis accelerates ulcer healing and can be used to study pancreatic and colorectal cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis | BCL
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1850293-95-6
  • Formula Weight
    311.2
  • Molecular Formula
    C12H12N2O3Se
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N#C[Se]CCNC(=O)C=1C=CC=CC1OC(=O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • HFY-4A

    HFY-4A is a novel HDAC inhibitor.HFY-4A has antitumour activity and has shown antiproliferative activity in breast cancer cells.

  • W146

    W146 is a selective and potent Sphingosine 1-phosphate receptor subtype 1 (S1PR1) antagonist that induces significant but transient hematolymphopenia in mice.

  • Kinetin riboside

    A cytokinin analog that displays potent antiproliferative activity against various human cancer cell lines.